The next wave of technological advancement in biotechnology and the pharma industry is about bringing convenience and ease to the administration of drugs. The growth in the injectable market and increasing awareness of self-administration are driving pharma companies to come up with new and innovative products with increased drug delivery convenience and safety. In the customized medical injectable market, one company that has started gaining traction is Unilife (UNIS).
Understanding the business:
The company is in the business of design, development, manufacturing, and supply of injectable products. Its products are designed with focus on safety that removes risk of needle-stick injury and unsafe injection practices.
Unilife has four main sources of revenue:
1. Customization program: In this...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|